Felix Faupel, Chief Commercial Officer at Bacthera, discussed how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market.
The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy with proven effectiveness, including identifying cancer in its earliest stages
The findings of a new research suggest that a mother’s diet during nursing influences her offspring’s microbiota composition, gut health and predisposition to become obese.
The findings of a new research suggest that the gut microbiota can influence binge-eating of sweet foods.
Gynecologist Franco Vicariotto and Virginia Franco, CEO and Co-Founder Yoni Solutions, discuss how personalized analysis and personalized therapy are within the reach of today's woman.
Funding round led by Shanghai Healthcare Capital. The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics.
The findings of a new research suggest that dietary and antibacterial strategies may help to prevent neutropenia-related fever after cancer therapy.
The findings of a new research suggest that obesity-induced changes in the vaginal microbiota can affect the immune responses against viral infection.
The findings of a new research support the link between gut microbes and depression, and suggest that the gut microbiota can be a target for future therapies.
Biopharma companies are currently developing Live Biotherapeutic Products. We discussed this topic with Morten Isaksen (BIO-ME).
